Woodcock Highlights US FDA Opioid Plans Amid Sen. Manchin And Others’ Criticisms

 
• By Derrick Gingery

The statement outlining opioid priorities in the FDA’s FY 2022 budget request comes on the heels of Sen. Manchin’s criticism of the acting commissioner and FDA opioid policy.

Opioids and money
The FDA wants to add labs to some international mail facilities to enhance screening for illicit opioid shipments coming into the US. • Source: Alamy

More from Legislation

More from Pink Sheet